We are live on ! Find out more
CLLS

Cellectis

32 hedge funds and large institutions have $32.5M invested in Cellectis in 2026 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 14 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,100% more call options, than puts

Call options by funds: $42K | Put options by funds: $1K

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

0.41% less ownership

Funds ownership: 14.63%14.22% (-0.41%)

6% less funds holding

Funds holding: 3432 (-2)

36% less capital invested

Capital invested by funds: $51.1M → $32.5M (-$18.6M)

79% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 14

Holders
32
Holders Change
-2
Holders Change %
-5.88%
% of All Funds
0.39%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
4
Increased
3
Reduced
14
Closed
4
Calls
$42K
Puts
$1K
Net Calls
+$41K
Net Calls Change
-$19K

CLLS Hedge Fund Activity: Q1 2026 in Review

32 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q1 2026, worth a combined $32.5M — down 36% from $51.1M a quarter earlier.

Fund positioning in CLLS was balanced in Q1 2026: 4 funds opened new positions, 4 closed out, 3 added to existing stakes and 14 trimmed.

The largest buyer was XTX Topco, opening a new position worth an estimated $62.4K. The largest seller was Marshall Wace, cutting an estimated $527K.

  • 32 institutional investors held Cellectis (CLLS) as of Q1 2026, down from 34 in Q4 2025.
  • Funds reported $32.5M of Cellectis stock for Q1 2026, down 36% quarter-over-quarter.
  • 4 funds opened new Cellectis positions in Q1 2026 and 4 closed out, a net change of 0 holders.
  • The largest Cellectis buyer in Q1 2026 was XTX Topco, an estimated $62.4K added.
  • The largest Cellectis seller in Q1 2026 was Marshall Wace, an estimated $527K sold.

Based on aggregated 13F filings for Q1 2026.